parameter estimation tool (Simcyp)
90
Structured Review
Simcyp
parameter estimation tool
Parameter Estimation Tool, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parameter+estimation+tool/parameter+estimation+tool/pmc10893163-79-29-33
Average 90 stars, based on 1 article reviews
Parameter Estimation Tool, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parameter+estimation+tool/parameter+estimation+tool/pmc10893163-79-29-33
Average 90 stars, based on 1 article reviews
parameter estimation tool - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations. Article Snippet: This article is protected by copyright.. All rights reserved.. Pregnancy is associated with numerous physiologic changes that influence absorption, distribution, metabolism and excretion. Article Title: Modelling and simulation approaches to support formulation optimization, clinical development and regulatory assessment of the topically applied formulations - Nimesulide solution gel case study. Article Snippet: The objective of the study was to show how mechanistic modelling can be used to characterize the skin absorption of Nimesulide (NIM) in both in vitro systems and in vivo subjects.. A basic PBPK model for oral absorption to characterize the systemic disposition of NIM and MPML MechDermATM models for in vitro permeation and in vivo, topical absorption was developed and verified using published data.. The developed models utilize drug physicochemical properties, formulation attributes and physiology information either collected from literature and/or from Simcyp databases (systems’ data). Inhibition:Article Title: Physiologically-based pharmacokinetic/pharmacodynamic modeling to predict tumor growth inhibition and the efficacious dose of selective estrogen receptor degraders in humans. Article Snippet: Correspondence Tom De Bruyn, Genentech Building 42, 475 E Grand Ave., South San Francisco, CA 94080, USA.. Email: debruynt@gene.com Abstract GDC‐9545 (giredestrant) is a highly potent, nonsteroidal, oral selective estrogen receptor antagonist and degrader that is being developed as a best‐in‐class drug candidate for early‐stage and advanced drug‐resistant breast cancer.. GDC‐9545 was designed to improve the poor absorption and metabolism of its predecessor GDC‐0927, for which development was halted due to a high pill burden. Concentration Assay:Article Title: Physiologically-based pharmacokinetic/pharmacodynamic modeling to predict tumor growth inhibition and the efficacious dose of selective estrogen receptor degraders in humans. Article Snippet: Correspondence Tom De Bruyn, Genentech Building 42, 475 E Grand Ave., South San Francisco, CA 94080, USA.. Email: debruynt@gene.com Abstract GDC‐9545 (giredestrant) is a highly potent, nonsteroidal, oral selective estrogen receptor antagonist and degrader that is being developed as a best‐in‐class drug candidate for early‐stage and advanced drug‐resistant breast cancer.. GDC‐9545 was designed to improve the poor absorption and metabolism of its predecessor GDC‐0927, for which development was halted due to a high pill burden. Derivative Assay:Article Title: Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets Article Snippet: .. The enzyme kinetic parameters were derived from the study of Bloomer et al., 1997 [ ], whereas fraction unbound in incubation media was optimized using the clinical dataset and Incubation:Article Title: Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets Article Snippet: .. The enzyme kinetic parameters were derived from the study of Bloomer et al., 1997 [ ], whereas fraction unbound in incubation media was optimized using the clinical dataset and |